Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent Surgery

NCT04233073 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped Limited value as a single-arm study

Conditions

Surgery

Interventions

DRUG: andexanet alfa

Sponsor

Alexion Pharmaceuticals, Inc.